Literature DB >> 20888269

MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development.

Ryan M O'Connell1, Daniel Kahn, William S J Gibson, June L Round, Rebecca L Scholz, Aadel A Chaudhuri, Melissa E Kahn, Dinesh S Rao, David Baltimore.   

Abstract

Mammalian noncoding microRNAs (miRNAs) are a class of gene regulators that have been linked to immune system function. Here, we have investigated the role of miR-155 during an autoimmune inflammatory disease. Consistent with a positive role for miR-155 in mediating inflammatory responses, Mir155(-/-) mice were highly resistant to experimental autoimmune encephalomyelitis (EAE). miR-155 functions in the hematopoietic compartment to promote the development of inflammatory T cells including the T helper 17 (Th17) cell and Th1 cell subsets. Furthermore, the major contribution of miR-155 to EAE was CD4(+) T cell intrinsic, whereas miR-155 was also required for optimum dendritic cell production of cytokines that promoted Th17 cell formation. Our study shows that one aspect of miR-155 function is the promotion of T cell-dependent tissue inflammation, suggesting that miR-155 might be a promising therapeutic target for the treatment of autoimmune disorders.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20888269      PMCID: PMC2966521          DOI: 10.1016/j.immuni.2010.09.009

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  44 in total

1.  MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene.

Authors:  Shuai Jiang; Hong-Wei Zhang; Ming-Hua Lu; Xiao-Hong He; Yong Li; Hua Gu; Mo-Fang Liu; En-Duo Wang
Journal:  Cancer Res       Date:  2010-03-30       Impact factor: 12.701

2.  Src homology 2 domain-containing inositol-5-phosphatase 1 (SHIP1) negatively regulates TLR4-mediated LPS response primarily through a phosphatase activity- and PI-3K-independent mechanism.

Authors:  Huazhang An; Hongmei Xu; Minghui Zhang; Jun Zhou; Tao Feng; Cheng Qian; Runzi Qi; Xuetao Cao
Journal:  Blood       Date:  2005-02-08       Impact factor: 22.113

3.  Silencing of SOCS1 enhances antigen presentation by dendritic cells and antigen-specific anti-tumor immunity.

Authors:  Lei Shen; Kevin Evel-Kabler; Randy Strube; Si-Yi Chen
Journal:  Nat Biotechnol       Date:  2004-11-21       Impact factor: 54.908

4.  B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization.

Authors:  P Hjelmström; A E Juedes; J Fjell; N H Ruddle
Journal:  J Immunol       Date:  1998-11-01       Impact factor: 5.422

5.  Compromised humoral and delayed-type hypersensitivity responses in IL-23-deficient mice.

Authors:  Nico Ghilardi; Noelyn Kljavin; Qi Chen; Sophie Lucas; Austin L Gurney; Frederic J De Sauvage
Journal:  J Immunol       Date:  2004-03-01       Impact factor: 5.422

6.  IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines.

Authors:  P Schwarzenberger; V La Russa; A Miller; P Ye; W Huang; A Zieske; S Nelson; G J Bagby; D Stoltz; R L Mynatt; M Spriggs; J K Kolls
Journal:  J Immunol       Date:  1998-12-01       Impact factor: 5.422

7.  IL-23 drives a pathogenic T cell population that induces autoimmune inflammation.

Authors:  Claire L Langrish; Yi Chen; Wendy M Blumenschein; Jeanine Mattson; Beth Basham; Jonathan D Sedgwick; Terrill McClanahan; Robert A Kastelein; Daniel J Cua
Journal:  J Exp Med       Date:  2005-01-17       Impact factor: 14.307

8.  Aberrant T cell differentiation in the absence of Dicer.

Authors:  Stefan A Muljo; K Mark Ansel; Chryssa Kanellopoulou; David M Livingston; Anjana Rao; Klaus Rajewsky
Journal:  J Exp Med       Date:  2005-07-11       Impact factor: 14.307

9.  Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis.

Authors:  J L McQualter; R Darwiche; C Ewing; M Onuki; T W Kay; J A Hamilton; H H Reid; C C Bernard
Journal:  J Exp Med       Date:  2001-10-01       Impact factor: 14.307

10.  Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation.

Authors:  Craig A Murphy; Claire L Langrish; Yi Chen; Wendy Blumenschein; Terrill McClanahan; Robert A Kastelein; Jonathon D Sedgwick; Daniel J Cua
Journal:  J Exp Med       Date:  2003-12-08       Impact factor: 14.307

View more
  409 in total

1.  The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-α.

Authors:  Shu Zhu; Wen Pan; Xinyang Song; Yan Liu; Xinrui Shao; Yuanjia Tang; Dong Liang; Dongyi He; Honglin Wang; Wenjun Liu; Yufang Shi; John B Harley; Nan Shen; Youcun Qian
Journal:  Nat Med       Date:  2012-07       Impact factor: 53.440

2.  miR-155 promotes T follicular helper cell accumulation during chronic, low-grade inflammation.

Authors:  Ruozhen Hu; Dominique A Kagele; Thomas B Huffaker; Marah C Runtsch; Margaret Alexander; Jin Liu; Erin Bake; Wei Su; Matthew A Williams; Dinesh S Rao; Thomas Möller; Gwenn A Garden; June L Round; Ryan M O'Connell
Journal:  Immunity       Date:  2014-10-16       Impact factor: 31.745

3.  Regulation of acute graft-versus-host disease by microRNA-155.

Authors:  Parvathi Ranganathan; Catherine E A Heaphy; Stefan Costinean; Nicole Stauffer; Caroline Na; Mehdi Hamadani; Ramasamy Santhanam; Charlene Mao; Patricia A Taylor; Sukhinder Sandhu; Gang He; Arwa Shana'ah; Gerard J Nuovo; Alessandro Lagana; Luciano Cascione; Susanna Obad; Oliver Broom; Sakari Kauppinen; John C Byrd; Michael Caligiuri; Danilo Perrotti; Gregg A Hadley; Guido Marcucci; Steven M Devine; Bruce R Blazar; Carlo M Croce; Ramiro Garzon
Journal:  Blood       Date:  2012-03-09       Impact factor: 22.113

4.  Interferon regulatory factor 3 inhibits astrocyte inflammatory gene expression through suppression of the proinflammatory miR-155 and miR-155*.

Authors:  Leonid Tarassishin; Olivier Loudig; Avital Bauman; Bridget Shafit-Zagardo; Hyeon-Sook Suh; Sunhee C Lee
Journal:  Glia       Date:  2011-12       Impact factor: 7.452

Review 5.  Translating the Untranslated Region.

Authors:  Johannes Schwerk; Ram Savan
Journal:  J Immunol       Date:  2015-10-01       Impact factor: 5.422

6.  Staphylococcal enterotoxin B-induced microRNA-155 targets SOCS1 to promote acute inflammatory lung injury.

Authors:  Roshni Rao; Sadiye Amcaoglu Rieder; Prakash Nagarkatti; Mitzi Nagarkatti
Journal:  Infect Immun       Date:  2014-04-28       Impact factor: 3.441

7.  MicroRNA-155 Modulates Acute Graft-versus-Host Disease by Impacting T Cell Expansion, Migration, and Effector Function.

Authors:  Nina C Zitzer; Katiri Snyder; Xiamoei Meng; Patricia A Taylor; Yvonne A Efebera; Steven M Devine; Bruce R Blazar; Ramiro Garzon; Parvathi Ranganathan
Journal:  J Immunol       Date:  2018-05-02       Impact factor: 5.422

Review 8.  MicroRNAs in immune response and macrophage polarization.

Authors:  Gang Liu; Edward Abraham
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-02       Impact factor: 8.311

9.  Rat mir-155 generated from the lncRNA Bic is 'hidden' in the alternate genomic assembly and reveals the existence of novel mammalian miRNAs and clusters.

Authors:  Paolo Uva; Letizia Da Sacco; Manuela Del Cornò; Antonella Baldassarre; Paola Sestili; Massimiliano Orsini; Alessia Palma; Sandra Gessani; Andrea Masotti
Journal:  RNA       Date:  2013-01-17       Impact factor: 4.942

Review 10.  Potential function of miRNAs in herpetic stromal keratitis.

Authors:  Sachin Mulik; Siddheshvar Bhela; Barry T Rouse
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-17       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.